Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?
Identifieur interne : 000276 ( Main/Exploration ); précédent : 000275; suivant : 000277Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?
Auteurs : Salvatore Galati ; Alessandro StefaniSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.
Abstract
With the silver anniversary of deep brain stimulation (DBS) behind us, this would seem to be a good juncture to consider its successes and unanswered questions. Bilateral subthalamic nucleus (STN) stimulation has changed the clinical perspective of several thousand Parkinson's disease (PD) patients worldwide. A recent reappraisal animates the field with strong arguments in favor of an anticipation of the stereotactic approach in patients with as little as 5 to 6 years of disease history if they manifest motor complications. From what was once a no-choice option, STN-DBS is now becoming more and more attractive to neurologists dealing with movement disorders. Despite the development of new pharmacological treatment and renewed rehabilitation programs able to modify the severity of drug-related complications, a resurgence of stimulation therapy reminiscent of an old era of medicine with an attendant blinkered mindset has emerged. Yet, the DBS-mediated effects are modest on critical aspects such as gait impairment and extremely variable depending on the clinical phenotype and individual clinical profile. Hence, the indication for DBS should become more, and not less, individually tailored. Those physicians considering deep brain stimulation (DBS) as a therapeutic option need to evaluate results beyond short-term quality of life, giving the correct weight to the direct and indirect costs over the longer term as well as to life prognosis. Unequivocal recourse to early-stimulation surgery necessitates investigations not limited to a mere comparative assessment versus drug-mediated benefits, but instead showing evidence of a clear degree of disease-modifying effect or a rescue of basal ganglia plasticity.
DOI: 10.1002/mds.26149
PubMed: 25649375
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000268
- to stream PubMed, to step Curation: 000268
- to stream PubMed, to step Checkpoint: 000277
- to stream Ncbi, to step Merge: 004241
- to stream Ncbi, to step Curation: 004241
- to stream Ncbi, to step Checkpoint: 004241
- to stream Main, to step Merge: 000276
- to stream Main, to step Curation: 000276
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?</title><author><name sortKey="Galati, Salvatore" sort="Galati, Salvatore" uniqKey="Galati S" first="Salvatore" last="Galati">Salvatore Galati</name><affiliation><nlm:affiliation>Neurocenter of Southern Switzerland.</nlm:affiliation><wicri:noCountry code="no comma">Neurocenter of Southern Switzerland.</wicri:noCountry></affiliation></author><author><name sortKey="Stefani, Alessandro" sort="Stefani, Alessandro" uniqKey="Stefani A" first="Alessandro" last="Stefani">Alessandro Stefani</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25649375</idno><idno type="pmid">25649375</idno><idno type="doi">10.1002/mds.26149</idno><idno type="wicri:Area/PubMed/Corpus">000268</idno><idno type="wicri:Area/PubMed/Curation">000268</idno><idno type="wicri:Area/PubMed/Checkpoint">000277</idno><idno type="wicri:Area/Ncbi/Merge">004241</idno><idno type="wicri:Area/Ncbi/Curation">004241</idno><idno type="wicri:Area/Ncbi/Checkpoint">004241</idno><idno type="wicri:Area/Main/Merge">000276</idno><idno type="wicri:Area/Main/Curation">000276</idno><idno type="wicri:Area/Main/Exploration">000276</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?</title><author><name sortKey="Galati, Salvatore" sort="Galati, Salvatore" uniqKey="Galati S" first="Salvatore" last="Galati">Salvatore Galati</name><affiliation><nlm:affiliation>Neurocenter of Southern Switzerland.</nlm:affiliation><wicri:noCountry code="no comma">Neurocenter of Southern Switzerland.</wicri:noCountry></affiliation></author><author><name sortKey="Stefani, Alessandro" sort="Stefani, Alessandro" uniqKey="Stefani A" first="Alessandro" last="Stefani">Alessandro Stefani</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">With the silver anniversary of deep brain stimulation (DBS) behind us, this would seem to be a good juncture to consider its successes and unanswered questions. Bilateral subthalamic nucleus (STN) stimulation has changed the clinical perspective of several thousand Parkinson's disease (PD) patients worldwide. A recent reappraisal animates the field with strong arguments in favor of an anticipation of the stereotactic approach in patients with as little as 5 to 6 years of disease history if they manifest motor complications. From what was once a no-choice option, STN-DBS is now becoming more and more attractive to neurologists dealing with movement disorders. Despite the development of new pharmacological treatment and renewed rehabilitation programs able to modify the severity of drug-related complications, a resurgence of stimulation therapy reminiscent of an old era of medicine with an attendant blinkered mindset has emerged. Yet, the DBS-mediated effects are modest on critical aspects such as gait impairment and extremely variable depending on the clinical phenotype and individual clinical profile. Hence, the indication for DBS should become more, and not less, individually tailored. Those physicians considering deep brain stimulation (DBS) as a therapeutic option need to evaluate results beyond short-term quality of life, giving the correct weight to the direct and indirect costs over the longer term as well as to life prognosis. Unequivocal recourse to early-stimulation surgery necessitates investigations not limited to a mere comparative assessment versus drug-mediated benefits, but instead showing evidence of a clear degree of disease-modifying effect or a rescue of basal ganglia plasticity.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Galati, Salvatore" sort="Galati, Salvatore" uniqKey="Galati S" first="Salvatore" last="Galati">Salvatore Galati</name><name sortKey="Stefani, Alessandro" sort="Stefani, Alessandro" uniqKey="Stefani A" first="Alessandro" last="Stefani">Alessandro Stefani</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000276 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000276 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25649375
|texte= Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25649375" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |